Pharmaceutical Composition Comprising an Anti-Bacterial Agent and an Active Ingredient Selected From Carveol, Thymol, Eugenol, Borneol and Carvacrol

A pharmaceutical composition comprising:

• at least one first therapeutically active substance selected from the group consisting of carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, beta-ionone, and isomers, derivatives or mixtures thereof;
• and
• at least one second therapeutically active substance which is an antibiotic selected from the group consisting of beta-lactams, cephalosporins, tetracyclines, rifamycins, peptides, amino sides, phenicols, macrolides, and derivatives or mixtures thereof.

A kit comprising:

• at least one first container containing a first therapeutically active substance selected from the group consisting of carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, beta-ionone and isomers, derivatives or mixtures thereof;
• and
• at least one second container containing a second therapeutically active substance which is an antibiotic selected from the group consisting of beta-lactams, cephalosporins, tetracyclines, rifamycins, peptides, aminosides, phenicols, macrolides and derivatives or mixtures thereof.

A method for treating an infection caused by bacteria comprising the simultaneous or sequential administration to a patient of:

• at least one first therapeutically active substance selected from the group consisting of carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, beta-ionone, and isomers, derivatives or mixtures thereof, and
• at least one second therapeutically active substance which is an antibiotic selected from the group consisting of the beta-lactams, cephalosporins, tetracyclines, rifamycins, peptides, amino sides, phenicols, macrolides and derivatives or mixtures thereof.